Mandate
Ensure a “watchdog” role, providing strategy and direction in the identification of problems and trends affecting the industry and how they are managed as issues (research-investigation-strategies), trying to cover a very broad spectrum of stakeholders in the cluster.
Achievements
- Identify the issues and trends that will have an overall effect on the life sciences sector and implement the tools required to try to predict the changes that will have an impact on the sector;
- focus on the creation of a Observatoire des sciences de la vie (unofficial translation: Life Sciences Observatory) that would centralize the data from the sector, identify emerging issues in order to better identify and prioritize the actions to undertake;
For more information about this strategic commitee, please read about it in the most recent Activity Report.
- Round Table for the positioning of LSHT with the federal government continues its work to monitor and influence federal public policies to ensure they are favourable to the LSHT sector
Members of the Strategic Committee
Coordinator of the Strategic Committee
Sabrina Bernier
Director - Communications and Public Affairs
- Didier Leconte, Coprésident
Fonds de solidarité FTQ - Marc Osborne, Coprésident
Roche Diagnostics - Frank Béraud
Montréal InVivo - Christian Bernard
Montréal International - Sabrina Bernier
Montréal InVivo - Michel Bouvier
Université de Montréal - Anthony T. Chung
Engene Inc - Vanessa Claveau
Ministère de l’Économie, de la Science et de l’Innovation, Gouvernement du Québec - Pierre-Alexandre Fournier
Hexoskin - Julie Insley
Innovation, Sciences et Développement économique - François Laflamme
Eli Lilly Canada - Irène Marcheterre
Centre Hospitalier de l’Université de Montréal - Anie Perrault
BioQuébec - Shane Russell
Medtronic
Members of the round table for the federal positioning of LSHT
- Nadège Adam
3M - Frédéric Alberro
Médicaments Novateurs Canada - Sébastien Beauchamp
Baxter Corporation - Nadine Beauger
Institut de recherche en immunologie et en cancérologie, Commercialisation de la recherche - Anne-Sophie Belzile
Médicaments Novateurs Canada - Frank Béraud
Montréal InVivo - François Bergeron
AccelLAB - Joanne Castonguay
Institut de recherche en politiques publiques - François Drolet
Roche Diagnostics - Julie Insley
Innovation, sciences et développement économique du Canada - Diane Gosselin
CQDM - François Laflamme- Responsable de table
Eli Lilly Canada - Grazia Maion
Univalor